Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pro-oxidant copper binding sites are specific structural motifs found on proteins such as amyloid-beta (Aβ), alpha-synuclein, and the prion protein, which coordinate copper ions (Cu+/Cu2+) to form redox-active complexes (Bush, 2003, PMID: 12757816). These sites facilitate metal-catalyzed oxidation (MCO), a process where the bound copper undergoes redox cycling in the presence of biological reductants like ascorbate, leading to the catalytic production of reactive oxygen species (ROS) such as hydrogen peroxide and hydroxyl radicals (Barnham & Bush, 2014, PMID: 24737124). The resulting oxidative stress is a primary driver of neuronal damage, lipid peroxidation, and protein aggregation in neurodegenerative conditions like Alzheimer's and Parkinson's diseases (Fallon et al., 2021, PMID: 33414134). Therapeutic intervention targets these sites using metal-protein attenuating compounds (MPACs) or metal ionophores, which aim to disrupt the pathological metal-protein interaction or stabilize the metal in a non-redox-active state. Unlike traditional chelators, these agents are designed to selectively target the labile metal pool associated with protein aggregates, thereby reducing oxidative damage and restoring metal homeostasis without causing systemic metal deficiency.
Metal-protein attenuation and redox silencing through competitive coordination or ionophore-mediated redistribution of copper ions from pathological protein complexes.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-oxidant copper binding sites.